NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss

Yahoo Finance20:19

Novo Nordisk's Weight-Loss Drug Retains Safety Profile Despite Concerns -- Market Talk

1204 GMT - Novo Nordisk's semaglutide--the active ingredient in its blockbuster weight-loss and diabetes treatments--belongs to one of the most derisked therapeutic drug classes in history from a safe

WSJ20:04

A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.

A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.

Zhitong Finance14:42

Can it cause blindness? Research shows that the weight loss drug Ozempic is related to a rare blindness condition, and weight loss drug concept stocks have fallen.

Hidden risk of rare blindness.

Gelonghui Finance11:52

A Harvard study shows a link between weight loss drug Ozempic and rare vision loss, causing a nearly 5% drop in novo-nordisk a/s stocks.

Some doctors have pointed out that there is currently no evidence to prove a direct causal relationship between drug use and eye complications, as some cases only appear after several months of medication.

wallstreetcn08:31

US stocks closing | S&P, Nasdaq hit new highs again! Tesla rose nearly 35% in seven days, and Nvidia rose more than 4.5% overnight.

S&P has reached a new high for two consecutive days, NASDAQ has reached a new high for three consecutive days, and Dow's intraday decline has significantly narrowed. Google, Apple, Microsoft, Taiwan Semiconductor in the US stock market have all reached new highs. Tesla has risen by 35% in seven days, and the chip stock index has risen by nearly 2%.

wallstreetcn06:05